Suggestions that human MHC class II antigens might be differentiation markers of leukaemic cells (Schlossman et al., 1976) , and the demonstration that class II antigen expression is lost at the terminal stages of B cell differentiation, in both normal and malignant cells (Halper et al., 1978) date back almost a decade. These findings preceded the realization that MHC class II antigens are encoded by a large number of genes (Korman et al., 1985; . Recent detailed molecular studies of the structure of class II antigens , and their genes (Gustafsson et al., 1984) , and the availability of monoclonal antibodies recognizing specific products of the different class II loci 
Suggestions that human MHC class II antigens might be differentiation markers of leukaemic cells (Schlossman et al., 1976) , and the demonstration that class II antigen expression is lost at the terminal stages of B cell differentiation, in both normal and malignant cells (Halper et al., 1978) date back almost a decade. These findings preceded the realization that MHC class II antigens are encoded by a large number of genes (Korman et al., 1985; . Recent detailed molecular studies of the structure of class II antigens , and their genes (Gustafsson et al., 1984) , and the availability of monoclonal antibodies recognizing specific products of the different class II loci , have stimulated further interest in differentiation-related expression of class II antigens in cells of the B lymphoid series. These more recent advances offer means to examine in detail, the mechanisms regulating expression of class II antigens. The large numbers of immature cells from the peripheral blood of patients with B cell leukaemia, are an especially valuable source Correspondence: K. Guy. Received 24 October 1985. of material for serological and molecular studies of phenotypic change during B cell differentiation. The MHC class II antigens are important immunoregulatory molecules, and knowledge of their expression in B cell leukaemia and lymphoma may enhance understanding of the processes of malignant change.
In this review we (i) summarize our experiences in the serological analysis of class II antigen expression in B-cell leukaemia and lymphoma and (ii) try to address the possible functional consequences of apparently aberrant expression of the antigens in the pathogenesis of human B cell malignant disease. As a preliminary to this, the structure of MHC class II antigens, their expression . The DP, DQ and DR beta chain genes and their products, as well as the DQ alpha chains, are highly polymorphic (reviewed by Korman et al., 1985; . In the case of the DQ subregion, where both alpha and beta chains are polymorphic, the repertoire of class II antigens expressed may also be influenced by transcomplementary association of alpha chains of one DQ allele with beta chains of the other, to form hybrid molecules . (Guy et al., 1982) . Many antibodies regarded as framework-specific are now known to recognize only a proportion of the total class II pool of molecules. For example, a number of antibodies recognize DP and DR molecules but not DQ molecules (Shaw & DeMars, 1984; . Determinants recognized as the specific products of one locus in a given haplotype may be encoded by other class II genes in other haplotypes (Brodsky, 1984; Crumpton et al., 1984) . The antibodies currently used in our own studies of class II expression in human B cell malignancy are listed in Table I .
Expression of MHC class II antigens in normal tissues
A detailed knowledge of the expression of class II antigens in normal tissue is essential for the interpretation of results of studies on B cell malignancy, and in assessing possible effects of neoplastic change on the expression of these antigens. Class II antigens are predominantly expressed in cells of the B lymphocyte and the monocyte/macrophage series, although studies have shown that they are not confined to these tissues (Daar et al., 1984) . In some tissues class II expression is constitutive and in others, including a variety of malignant cell lines derived from solid tumours, is inducible with y-interferon or mitogens .
All normal peripheral blood B cells are class II positive, and express coordinately products of DP, DQ and DR loci (Nunez et al., 1984) . On average, -35% of the monocytes in normal peripheral blood are DR-positive and DQ-positive (Gonwa et al., 1983; Guy et al., 1983a; Nunez et al., 1984) , and most of the remainder are DR-positive and DQ-negative. It appears that only DR + DQ + monocytes are functionally active in antigen presentation (Gonwa et al., 1983) . Products of the DR and DQ loci are also non-coordinately expressed on activated T cells (Brown et al., 1984) . A variety of techniques have been used to determine the specifities of anti-human MHC class II reagents. These include two-dimensional polyacrylamide gel electrophoresis (Crumpton et al., 1984) and serological tests against deletion mutant cell lines (Shaw & De Mars, 1984) which have lost selectively the expression of products of one or more class II subregions. The specificities assigned above are intended to reflect the predominant pattern of reaction of the antibodies and these have usually been determined by tests on only a limited number of haplotypes. A few reagents, such as BT3/4, L243 and Leu 10 have been extensively characterized on cells representing most of the recognized DR alleles (Brodsky, 1984) . Because of the intricacy of the human class II region, it is possible that the subregion products recognized by the antibodies may vary on different MHC haplotypes. The assigned specificities should therefore be regarded only as provisional. DA6.147 reacts with isolated alpha chains, DA6.231, TU39 and DA6.164 react with beta chain determinants.
Immunohistochemical analysis of tissue sections and fluoresence activated cell sorter analysis of cell suspensions from peripheral lymphoid tissues (spleen, lymph node and tonsil) have similarly shown coordinate expression of DQ and DR antigens by most normal B cells (Hsu et al., 1984; Marti et al., 1985; Krajewski et al., 1985) . In all embryonic tissues studied, where there is expression of class II antigens, DR antigens appear before DQ antigens (Natali et al., 1984) . DP antigen expression, in the absence of DR and DQ expression, is also reported to occur on early embryonic lymphopoietic tissues (Edwards et al., 1985; Muller et al., 1985 (Okamura et al., 1982; Addis et al., 1982; van Heyningen et al., 1982) . Class II antigens are expressed on almost all B cells from the peripheral blood of all B cell CLL patients (Halper et al., 1979; Newman & Greaves, 1982; Okamura et al., 1982a; Guy et al., 1983a) . However, although the cells of all patients express DR antigens there is detectable expression of DP and DQ antigens on only a proportion of the cells in some cases (Figure 1 ) (Guy et al., 1983a; Swerdlow et al., 1984; Marti et al., 1985; Guy et al., 1986a) . The proportion of cells which is DP, DQ and DR-positive is highly variable from patient to patient. In many patients, cells expressing DP, DQ and DR antigens are the major population, and in others such cells comprise as little as 20% of the total, the remaining cells being DR-positive and DP/DQ-negative. In most cases of CLL the numbers of DP-positive cells are equal to the numbers of DQ-positive cells (although in the example illustrated there are a few more DP-than DQ-positive cells). (Table III) comprise a minority of the DR-positive population in CLL. It is possible that MHC class II expression is influenced by differences in proliferative activity of low grade and high grade lymphomas (Srigley et al., 1985) .
The most marked difference in expression of DR and DQ antigens so far found in NHL is in cases of centrocytic lymphoma: cells from five of seven patients fail to react with anti-DQ antibodies. In common with much earlier studies (Halper et al., 1978) in plasmacytomas, representative of the terminal stages of B cell differentiation, class II expression is usually weak or not detectable.
Discrepancies in reactivity between monoclonal antibodies detecting different determinants of DR antigens is sometimes found in NHL (Table III) . This is probably a result of the extensive polymorphism of class II antigens and is reflected in distinct haplotype preferences for binding of certain monoclonal antibodies (Shaw & DeMars, 1984) . For example, DA6.164 does not react with DR7 (van Heyningen et al., 1982) and has higher affinity for DR3 and DR5 cells than for cells of other DR types (unpublished results). These observations emphasize the necessity for using a panel of monoclonal antibodies when assessing class II expression and for caution in interpreting data even when a number of antibodies have been used. There may be an alternative explanation for the discepancies in the reactions of some anti-class II antibodies, such as DA6.164 and L243: the predominant reaction of DA6.164 is for a product of one of the number of DR encoded beta polypeptides (Crumpton et al., 1984) , whereas L243 recognizes all DR polypeptides in the haplotypes Figure 1 Cells from a CLL patient (JT) examined by indirect immunofluoresence and fluoresence activated cell sorter (FACS IV) as previously described (Guy et al., 1986b) (Guy et al., 1986a, b) . Other cases have higher and variable numbers of DP and DQ-positive cells (cf. Figure 2) . In patient JT, although only a minority of the cells are DP-positive (31%) and DQ-positive (22%; controls 2%) some of the cells are strongly DQ-positive (in channels 60-100). Cells from JT have also been treated with TPA (Guy et al., 1986a) and DQ expression is increased > 20 fold. In all cases of CLL after culture with TPA, DP and DQ antigens are expressed on > 85% of the cells. Prolymphocytic (3) Centrocytic small cell (6) Centrocytic large cell (1) Hairy cell leukaemia (3) Centroblastic-centrocytic follicular (17) diffuse (6) High grade Centroblastic (20)
Immunoblastic (5) Plasmacytoma (3) Lymphoblastic ( (5) + (5) neg (3) +++ (1) + (1) + + (1) (5) +++ (1) +++ (2) neg (1) (Krajewski et al., 1985) .
All (Shackelford et al., 1982) . This may suggest that products of the different DR beta chain genes are non-coordinately expressed. In all cases of NHL examined in the present study the anti-DQ antibodies TU22 and LeulO, which are directed to different determinants, have given equivalent results.
Expression of MHC class II antigens in hairy cell leukaemia
Hairy cell leukaemia (HCL) is a rare variant of lymphoid malignancy, in which the cells are commonly of the B cell lineage (Hermann et al., 1985) . Faille and colleagues (1984) examined a single case of HCL by biochemical means and showed that the cells expressed DR antigens but failed to express DQ antigens. DQ expression was induced by treating the cells with TPA, sodium butyrate or 5-azacytidine. We have examined five subjects with hairy cell leukaemia and in all cases, DR antigens are detectable on the majority of the cells. In one case, sections of spleen have been examined by immunohistochemistry and DQ antigen expression is undetectable (Krajewski et al., 1985) . Two further cases examined by immunohistochemistry show coordinate expression of class II antigens (Table III) . In two other cases, in which peripheral blood cells were examined by indirect immunofluoresence, DQ and DP antigen expression are detectable (in one case on almost all of the cells) (Figure 2 ). Cells have also been examined after culture with phorbol ester (vide infra).
In agreement with other studies (Korsmeyer et Channel number (log scale, fluorescence intensity) Figure 2 Cells from two cases of hairy cell leukaemia before and after culture of the cells with TPA. Cells were analysed as described in Figure 1 . In the first case (a), DP and DQ antigens are expressed on only a proportion of the cells before culture (i-v) and class II expression is much increased after culture with TPA (vi-x). In the second case (b), DP and DQ antigens are expressed on almost all of the cells before culture with TPA (i-v). After culture with TPA (vi-x) class II expression is much reduced and this involves reduction of DP, DQ and DR expression. DQ and DP expression are much reduced and detectable on only a very small proportion of the cells. Interleukin 2 receptor (anti-Tac antibody) is detectable in both cases on the untreated cells and is reduced in expression in both cases after culture of the cells with TPA.
cells in J5-positive, common acute lymphoblastic leukaemia (ALL) are committed to differentiation along a B cell pathway (Cossman et al., 1982 and that DQ expression is confined to a minority of the DR-positive cells.
The finding of heterogeneity of cell surface class II antigens in ALL is supported by quantitative studies in 37 cases of ALL, where it was found that the range of expression varied from patient to patient by more than ten fold (Okamura et al., 1984) . Similar results have been reported in CLL (Okamura et al., 1982a) .
Non-coordinate expression of DR and DQ antigens is also a feature of a number of established lines derived from cases of ALL Newman et al., 1983; Wang et al., 1983) . That is, the majority of cells from the lines are DRpositive and fewer cells are DQ-positive. In the study of Wang et al. (1983) the monoclonal anti-DP antibody ILR-1 was also reported to react with the majority of cells in the lines.
MHC class 11 determinants as allelic markers of B cell malignant disease
In a series of Edinburgh CLL patients studied, no evidence was found that MHC class I or class II antigens are markers of genetic susceptibility to B cell malignant disease. There was an association for a subgroup of patients lacking HLA-A1 and B8 with less need for treatment within a few months of diagnosis (Kilpatrick et al., 1984 ). Other studies have described an association between expression of the DQ determinant recognized by the monoclonal antibody IVD12 (anti-DQw3) and CLL: in the study of NunezRoldan et al. (1982) , 93% of patients with CLL were IVD12-positive (and DR4 or DR5-positive) in comparison with 50% of controls. Linkage disequilibrium accounts for the association of DQw3 with DR4 and DR5. In the Edinburgh study, only 40% of the patients, and an equivalent number of controls, were DR4 and/or DR5 positive (D.C. Kilpatrick, personal communication) . The reasons for the discrepancy may be a reflection of differences in the selection of patients, classification of the disease or of the ethnic origins of the subjects studied.
Stimulation of increased levels of MHC class II antigen expression in CLL with phorbol ester
The croton seed oil tumour-promoting agent 12-0-tetradecanoyl phorbol-13-acetate (TPA), introduced several years ago (Totterman et al., 1980) , has been used widely in studies on malignant B cells. TPA is an extremely powerful tool for dissecting events contributing to differentiation of leukaemic cells. The effects of TPA on morphology of CLL cells and on their ability to secrete immunoglobulin are consistent with induction of differentiation of the cells (Totterman et al., 1980; Okamura et al., 1982b) . Cells from some patients, but not others, enter S phase of the cell cycle after several days of culture with TPA (Godal et al., 1982) . In some cases there is also secretion of considerable quantities of immunoglobulin (reviewed by Gordon, 1984) . In all cases, irrespective of whether the cells enter S phase and/or secrete immunoglobulin, class II expression is markedly increased by culture of the cells with TPA (Totterman et al., 1981; Okamura et al., 1982; Guy et al., 1983a Guy et al., , 1983b Guy et al., 1986a, b) . The increases in class II expression are highly variable from patient to patient but appear to involve increased expression of DP, DQ and DR antigens in all cases (Guy et al., 1983a; Guy et al., 1986a, b) . An example of CLL cells examined before and after culture with TPA for 72 h is shown in Figure 3 . In the example illustrated, class II expression is increased about five fold by culture with TPA. In other cases, where class II expression is especially low on the untreated cells, increments of more than twenty fold in DQ expression are found (Guy et al., 1986a) . In all cases studied, DQ and DP antigens are detectable on >85% of the cells after culture with TPA, even in those cases where DP and DQ expression is confined to about 20% of the cells before culture (Guy et al., 1983a; Guy et al., 1986a) . Transferrin receptor and 4F2 expression are also increased by TPA treatment of the cells but the expression of Leu-1 is not substantially affected.
The appearance of increased levels of class II antigens at the cell surface in CLL is a reflection of increases in the steady state levels of class II specific mRNA transcripts, detectable with complementary DNA probes specific for DP, DQ and DR genes (Guy et al., 1986b; and unpublished results) . In samples examined from three patients, the levels of class II specific mRNA transcripts detected with cDNA probes parallel the levels of class II antigens at the cell surface detected with monoclonal antibodies. There is a need to establish in more extensive studies if the serological differences in class II expression at the cell surface are reflected at the mRNA level.
The proliferation centres of lymph node and involved splenic white pulp areas in B cell lymphocytic lymphoma preferentially stain with anti-DQ antibodies, in comparison with the surrounding cells, and as indicated previously (Swerdlow et al., 1984) in this respect they are Figure 1 ) and the increase in class II expression inducible with TPA. Cells from WT have been examined on a number of occasions and reported elsewhere (Guy et al., 1986a) . Cells were analysed as in Figure 1 . About 50-60% of the cells are DP-and DQ-positive before culture with TPA (panels i-v) and >90% after culture (vi-x Cells from two cases of hairy cell leukaemia (HCL) have been tested after culture with TPA ( Figure 2 ). In one case class II expression is increased and in the other class II expression is substantially reduced. This is unexpected, because class II expression after culture of CLL cells with TPA is almost invariably increased. These findings may suggest that some HCL (before culture with TPA) are analogous to TPA-activated CLL cells, and are close to terminal differentiation and loss of class II expression, which then occurs when the cells are cultured with TPA. Interleukin-2 (IL-2) receptor expression is also reduced in HCL after culture of the cells with TPA. The loss of IL-2 receptor is consistent with the suggestion that some HCL are close to terminal differentiation, as is the finding that plasma cell associated antigens are expressed in HCL (cited in Hermann et al., 1985) .
In only a single case of plasma cell leukaemia have the effects of TPA on cells at the terminal stages of B cell differentiation been tested (Guy et al., 1986b) . Class II expression is not induced in a class II-negative, class I-positive plasma cell leukaemia, suggesting that the ability to express the antigens is irrevocably lost at the plasma cell stage.
Cells from some patients with B cell leukaemia respond to TPA stimulation with high rates of immunoglobulin secretion. This will provide a valuable source of material for the production of anti-idiotype monoclonal antibodies for possible therapeutic use.
Functional consequences of anomalous MHC class II expression in B cell malignancy A major mechanism which regulates the interactions of cells comprising the immune system, involves recognition of class II molecules through specific receptors on the surface of T lymphocytes (Biddison et al., 1983) . Variation in the levels of expression of class II antigens and differences in the expression of products of the different class II loci, are likely to influence cellular interactions in the immune system. Since class II antigens are also expressed on non-lymphoid tissues, including vascular endothelia (Gronewegen et al., 1985; Muller et al., 1985) these effects may be more widespread than is at first evident.
It is conceivable that some cellular interactions involving class II antigens might predispose to the activation of T lymphocytes with suppressor activity (Palacios et al., 1983; Pawelec et al., 1984) . This would be a normal function of cellular immunity but could also be a contributory factor to the pathogenesis of malignancy of the B cell series. Among normal cells, both quantitative and qualitative differences in class II expression have functional consequences. For example, the ability of monocytes to present antigen to T cells correlates with the coordinate expression of DR and DQ antigens (Gonwa et al., 1983) . Class IIdependent allogeneic stimulation of T cells by monocytes is a function of quantitative variation in class II expression on the stimulator population (Nunez et al., 1985) . In this regard, cells from CLL patients are inefficient stimulators of allogeneic T lymphocytes (Halper et al., 1979) , unless the cells are first cultured with TPA (Okamura et al., 1982b) .
The growth and differentiation of B cells involves secretion of specific factors by T lymphocytes (reviewed by Howard & Paul, 1983 ) which bind to, and induce the maturation of the cells. Activation of B cells, and their entry into the cell cycle from a resting state, involves substantial increases in class II expression in both normal (Kehrl et al., 1985) and, as shown here, in malignant populations. Is increased cell surface class II expression on TPAtreated CLL cells a stimulus for T cell activation and subsequent synthesis of B cell growth and differentiation factors? Some findings suggest that this may be so. The TPA-induced differentiation of CLL cells which is characterized by morphological change, immunoglobulin secretion and cell cycle S phase entry (Gordon, 1984) is dependent on autologous helper T lymphocytes (Danersund et al., 1985) . TPA-induced increases in class II expression are T cell independent (unpublished results (Guy et al., 1986a) and are apparently unaffected by treatment of the disease.
The results of analysis of class II expression in CLL (and also in some normal tissues) imply that there may be independent regulatory elements for the different class II genes. This is in contrast to other studies which imply that the regulation of expression of products of the different class II genes is coordinate (Mach et al., 1984) . Furthermore, the expression of DQ antigens does not occur in malignant B cells unless there is also DR expression. This may suggest that there are regulatory mechanisms for DQ antigens which are inherent to the DR genes. The ability of CLL cells to respond with much increased class II expression after stimulation with TPA, will be of use in detailed molecular studies and the availability of large numbers of B cells from CLL patients will greatly help examination of the mechanisms of class II antigen regulation.
Further studies of cells from patients with B cell leukaemia and lymphoma will provide much valuable information on the structure and function of class II antigens, and this will be relevant to an understanding of the mechanisms governing their expression in normal tissues. 
